Trademarkia Logo

Canada

C$
AZURITY
REGISTERED

on 27 Apr 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

AZURITY PHARMACEUTICALS INC.

8 Cabot Road Suite 2000Woburn MA 01801

US

Serial Number

2000809 filed on 17th Oct 2019

Registration Number

TMA1127110 registered on 27th Apr 2022

Registration expiry Date

17th Oct 2029

Correspondent Address

GOWLING WLG (CANADA) LLP

TD Canada Trust TowerSuite 1600421 -7 Avenue SWCalgary

ALBERTA

CA

T2P4K9

AZURITY

Trademark usage description

pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inf Read More

Classification Information


Class [005]
Pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, anti-inflammatory treatment medicines, antimicrobial treatment medicines for oral use, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, bacterial infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical preparations for cardiovascular diseases and disorders, colitis, muscle spasm, bacterial infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceutical preparations with vancomycin, enalapril, lisinopril, amlodipine, lamotrigine, topiramate, zonisamide, omeprazole, baclofen, lansoprazole, metronidazole, progesterone, or methotrexate as the active pharmaceutical ingredient for cardiovascular diseases and disorders, colitis, muscle spasm, bacterial infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammatory, bacterial infection, and fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, bacterial infectious diseases, acidreflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2000809

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 25th Mar 2021
Search Recorded
Submitted for opposition 20
on 25th Mar 2021
Examiner's First Report
Submitted for opposition 223
on 25th Mar 2021
Total Provisional Refusal
Submitted for opposition 236
on 16th Feb 2021
Partial Withdrawal - Madrid Protocol
Submitted for opposition 256
on 12th Oct 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 12th Dec 2019
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 11th Dec 2019
Created
Submitted for opposition 31
on 11th Dec 2019
Formalized
Submitted for opposition 30
on 17th Oct 2019
Filed
Submitted for opposition 228
on 17th Oct 2019
International Registration